OBJECTIVE: To explore the feasibility of DNA methylation analysis for the detection of cervical neoplasia in self-obtained cervico-vaginal lavages. METHODS: Lavages collected by a self-sampling device and paired cervical scrapings were obtained from 20 cervical cancer patients and 23 patients referred with an abnormal cervical smear (15 with high-grade cervical intraepithelial neoplasia (CIN2+) and 8 without CIN). All lavages and scrapings were analyzed by liquid based cytology (LBC), Hybrid Capture II (HC-II) for hr-HPV DNA detection and by DNA methylation analysis (JAM3, TERT, EPB41L3 and C13ORF18). Concordance between lavages and scrapings was measured by Cohen's Kappa (k). RESULTS: In lavages and scrapings from cervical cancer patients (n=20), methylation analysis was positive in 19 (95%) and 19 (95%), HC-II in 16 (80%) and 15 (75%) and LBC in 15 (75%) and 19 (95%), respectively. In lavages and scrapings from CIN2+ patients (n=15), methylation analysis was positive in 10 (67%) and 12 (80%), HC-II in 15 (100%) and 15 (100%) and LBC in 11 (73%) and 12 (80%), respectively. Concordance between cervical scrapings and lavages (n=43) was for LBC k=0.522 (p<0.001), hr-HPV testing k=0.551 (p<0.001) and DNA methylation analysis k=0.653 (p<0.001). CONCLUSIONS: DNA methylation analysis in cervico-vaginal lavages obtained by a self-sampling device is feasible and its diagnostic performance appears to be at least comparable to the detection of cervical neoplasia by cytomorphology and hr-HPV. Our pilot study suggests that detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages warrants exploration of its use in large prospective studies.
OBJECTIVE: To explore the feasibility of DNA methylation analysis for the detection of cervical neoplasia in self-obtained cervico-vaginal lavages. METHODS: Lavages collected by a self-sampling device and paired cervical scrapings were obtained from 20 cervical cancerpatients and 23 patients referred with an abnormal cervical smear (15 with high-grade cervical intraepithelial neoplasia (CIN2+) and 8 without CIN). All lavages and scrapings were analyzed by liquid based cytology (LBC), Hybrid Capture II (HC-II) for hr-HPV DNA detection and by DNA methylation analysis (JAM3, TERT, EPB41L3 and C13ORF18). Concordance between lavages and scrapings was measured by Cohen's Kappa (k). RESULTS: In lavages and scrapings from cervical cancerpatients (n=20), methylation analysis was positive in 19 (95%) and 19 (95%), HC-II in 16 (80%) and 15 (75%) and LBC in 15 (75%) and 19 (95%), respectively. In lavages and scrapings from CIN2+ patients (n=15), methylation analysis was positive in 10 (67%) and 12 (80%), HC-II in 15 (100%) and 15 (100%) and LBC in 11 (73%) and 12 (80%), respectively. Concordance between cervical scrapings and lavages (n=43) was for LBC k=0.522 (p<0.001), hr-HPV testing k=0.551 (p<0.001) and DNA methylation analysis k=0.653 (p<0.001). CONCLUSIONS: DNA methylation analysis in cervico-vaginal lavages obtained by a self-sampling device is feasible and its diagnostic performance appears to be at least comparable to the detection of cervical neoplasia by cytomorphology and hr-HPV. Our pilot study suggests that detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages warrants exploration of its use in large prospective studies.
Authors: Renske D M Steenbergen; Peter J F Snijders; Daniëlle A M Heideman; Chris J L M Meijer Journal: Nat Rev Cancer Date: 2014-06 Impact factor: 60.716
Authors: Wina Verlaat; Barbara C Snoek; Daniëlle A M Heideman; Saskia M Wilting; Peter J F Snijders; Putri W Novianti; Annina P van Splunter; Carel F W Peeters; Nienke E van Trommel; Leon F A G Massuger; Ruud L M Bekkers; Willem J G Melchers; Folkert J van Kemenade; Johannes Berkhof; Mark A van de Wiel; Chris J L M Meijer; Renske D M Steenbergen Journal: Clin Cancer Res Date: 2018-04-09 Impact factor: 12.531
Authors: Nataša Vasiljević; Dorota Scibior-Bentkowska; Adam R Brentnall; Jack Cuzick; Attila T Lorincz Journal: Gynecol Oncol Date: 2014-02-06 Impact factor: 5.482
Authors: E Schuuring; G B A Wisman; A Boers; R Wang; R W van Leeuwen; H G Klip; G H de Bock; H Hollema; W van Criekinge; T de Meyer; S Denil; A G J van der Zee Journal: Clin Epigenetics Date: 2016-03-09 Impact factor: 6.551
Authors: Suzanne Snellenberg; Lise M A De Strooper; Albertus T Hesselink; Chris J L M Meijer; Peter J F Snijders; Daniëlle A M Heideman; Renske D M Steenbergen Journal: BMC Cancer Date: 2012-11-23 Impact factor: 4.430
Authors: Nina Milutin Gašperov; Ivan Sabol; Pavao Planinić; Goran Grubišić; Ivan Fistonić; Ante Ćorušić; Magdalena Grce Journal: PLoS One Date: 2015-06-09 Impact factor: 3.240
Authors: A Boers; R P Bosgraaf; R W van Leeuwen; E Schuuring; D A M Heideman; L F A G Massuger; V M J Verhoef; J Bulten; W J G Melchers; A G J van der Zee; R L M Bekkers; G B A Wisman Journal: Br J Cancer Date: 2014-07-17 Impact factor: 7.640